Duarte, JD; Dalton, R; Elchynski, AL; Smith, DM; Cicali, EJ; Lee, JC; Duong, BQ; Petry, NJ; Aquilante, CL; Beitelshees, AL; et al.
Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.
Genetics in Medicine.
2021;
23:2335-2341.
Strawn, JR; Poweleit, EA; Mills, JA; Schroeder, HK; Neptune, ZA; Specht, AM; Farrow, JE; Zhang, X; Martin, LJ; Ramsey, LB.
Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial.
Journal of Personalized Medicine.
2021;
11.
Miller, TP; DeGroote, NP; Pommert, L; Awoniyi, O; Board, S; Ugboh, N; Joshi, V; Ambrosino, N; Weisnicht, A; Hsiao, H; et al.
Comparison of Severe Toxicities Following High Dose Methotrexate Administration By Demographics and over Time in Pediatric Patients with Acute Lymphoblastic Leukemia.
Blood.
2021;
138:1970-1970.
Taylor, ZL; Thompson, LE; Bear, H; Mizuno, T; Vinks, AA; Ramsey, LB.
Toward pharmacogenetic SLCO1B1-guided dosing of methotrexate in arthritis using a murine Slco1b2 knockout model.
Clinical and Translational Science.
2021;
14:2267-2277.
Edwards, A; Teusink-Cross, A; Martin, LJ; Prows, CA; Mehta, PA; Ramsey, LB.
Influence of CYP2D6 metabolizer status on ondansetron efficacy in pediatric patients undergoing hematopoietic stem cell transplantation: A case series.
Clinical and Translational Science.
2021.
Lu, L; Mills, JA; Li, H; Schroeder, HK; Mossman, SA; Varney, ST; Cecil, KM; Huang, X; Gong, Q; Ramsey, LB; et al.
Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial.
Journal of the American Academy of Child and Adolescent Psychiatry.
2021;
60:1309-1318.
Strawn, JR; Poweleit, EA; Uppugunduri, CR S; Ramsey, LB.
Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors.
Frontiers in Pharmacology.
2021;
12.
Ramsey, LB.
52.2 AN UPDATE ON GENE-MEDICATION INTERACTIONS RELEVANT TO PEDIATRIC PSYCHOPHARMACOTHERAPY.
Journal of the American Academy of Child and Adolescent Psychiatry.
2021;
60.
Poweleit, E; Vaughn, S; Desta, Z; Strawn, J; Ramsey, L.
TU68. CYP2C19 METABOLIZER PHENOTYPE PREDICTS SERTRALINE PHARMACOKINETICS IN CHILDREN AND ADOLESCENTS.
European Neuropsychopharmacology.
2021;
51.
Bopp, EA; Poweleit, E; Cox, MO; Strawn, J; Farrow, JE; Duran, LP; Prows, CA; Ramsey, L; DelBello, M.
11.2 Adjunctive L-Methylfolate in Children and Adolescents With Mood Disorders.
Journal of the American Academy of Child and Adolescent Psychiatry.
2021;
60.
Vaughn, S; Poweleit, E; Desta, Z; Strawn, J; Ramsey, L.
32.4 CYP2C19 Metabolizer Status Predicts Escitalopram Pharmacokinetics in Children and Adolescents.
Journal of the American Academy of Child and Adolescent Psychiatry.
2021;
60.
Vaughn, S; Sarangdhar, M; Poweleit, E; Strawn, J; Ramsey, L.
32.5 The Combination of CYP2C19 Metabolized Antidepressants and Cannabinoids Presents Elevated Risk of Antidepressant-Related Side Effects.
Journal of the American Academy of Child and Adolescent Psychiatry.
2021;
60:s215-s216.
Tuteja, S; Salloum, RG; Elchynski, AL; Smith, DM; Rowe, E; Blake, KV; Limdi, NA; Aquilante, CL; Bates, J; Beitelshees, AL; et al.
Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy.
Clinical and Translational Science.
2021.
Hertz, DL; Arwood, MJ; Stocco, G; Singh, S; Karnes, JH; Ramsey, LB.
Planning and Conducting a Pharmacogenetics Association Study.
Clinical Pharmacology and Therapeutics.
2021;
110:688-701.
Hertz, DL; Ramsey, LB; Gopalakrishnan, M; Leeder, JS; Van Driest, SL.
Analysis Approaches to Identify Pharmacogenetic Associations With Pharmacodynamics.
Clinical Pharmacology and Therapeutics.
2021;
110:589-594.
Giacomini, KM; Karnes, JH; Crews, KR; Monte, AA; Murphy, WA; Oni-Orisan, A; Ramsey, LB; Yang, JJ; Whirl-Carrillo, M.
Advancing Precision Medicine Through the New Pharmacogenomics Global Research Network.
Clinical Pharmacology and Therapeutics.
2021;
110:559-562.
Ramsey, LB; Gaedigk, A.
CYP2D6*9 and *41: Does the Activity Value Assigned to these Alleles Need to be Reduced to more Accurately Predict Phenotype?.
Clinical Pharmacology and Therapeutics.
2021.
Hicks, JK; El Rouby, N; Ong, HH; Schildcrout, JS; Ramsey, LB; Shi, Y; Anne Tang, L; Aquilante, CL; Beitelshees, AL; Blake, KV; et al.
Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.
Clinical Pharmacology and Therapeutics.
2021;
110:179-188.
Vaughn, SE; Strawn, JR; Poweleit, EA; Sarangdhar, M; Ramsey, LB.
The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations.
Journal of Personalized Medicine.
2021;
11.
Taylor, ZL; Vang, J; Lopez-Lopez, E; Oosterom, N; Mikkelsen, T; Ramsey, LB.
Systematic Review of Pharmacogenetic Factors That Influence High-Dose Methotrexate Pharmacokinetics in Pediatric Malignancies.
Cancers.
2021;
13.
Ramsey, LB; Namerow, LB; Bishop, JR; Hicks, JK; Bousman, C; Croarkin, PE; Mathews, CA; Van Driest, SL; Strawn, JR.
Thoughtful Clinical Use of Pharmacogenetics in Child and Adolescent Psychopharmacology.
Journal of the American Academy of Child and Adolescent Psychiatry.
2021;
60:660-664.
Rossow, KM; Vaughn, SE; Strawn, JR; Van Driest, SL; Ramsey, LB.
The need for a refined understanding of CYP2D6 in second-generation antipsychotic outcomes in children and adolescents.
Pharmacogenomics.
2021;
22:447-450.
Hamill Skoch, S; Mills, JA; Ramsey, L; Strawn, JR.
Letter to the Editor: Sleep Disturbances in Selective Serotonin Reuptake Inhibitor-Treated Youth with Anxiety Disorders and Obsessive Compulsive Disorder-A Bayesian Hierarchical Modeling Meta-Analysis.
Journal of Child and Adolescent Psychopharmacology.
2021;
31:387-388.
Tang Girdwood, SC; Rossow, KM; Van Driest, SL; Ramsey, LB.
Perspectives from the Society for Pediatric Research: pharmacogenetics for pediatricians.
Pediatric Research.
2021.
Brown, JT; Ramsey, LB; Van Driest, SL; Aka, I; Colace, SI.
Characterizing Pharmacogenetic Testing Among Children's Hospitals.
Clinical and Translational Science.
2021;
14:692-701.
Jallaq, SA; Verba, M; Strawn, JR; Martin, LJ; DelBello, MP; Ramsey, LB.
CYP2D6 Phenotype Influences Aripiprazole Tolerability in Pediatric Patients with Mood Disorders.
Journal of Child and Adolescent Psychopharmacology.
2021;
31:56-62.